Back
AnaptysBio Vs. Ocular Therapeutix Industry Stock Comparison
Buy
55
ANAB
AnaptysBio
Last Price:
25.07
Seasonality Move:
-7.52%
Buy
69
OCUL
Ocular Therapeutix
Last Price:
6.18
Seasonality Move:
-2.15%
Buy
55
AnaptysBio (ANAB)
is a Buy
Is AnaptysBio a Buy, Sell or Hold?
- The current AnaptysBio [ANAB] share price is $25.07. The Score for ANAB is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- ANAB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
69
Ocular Therapeutix (OCUL)
is a Buy
Is Ocular Therapeutix a Buy, Sell or Hold?
- The current Ocular Therapeutix [OCUL] share price is $6.17. The Score for OCUL is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- OCUL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ANAB Stock Price Chart
What is AnaptysBio's stock price today?
-
The AnaptysBio share price today is $25.07
The current trend is moderately bullish and ANAB is experiencing slight buying pressure.
OCUL Stock Price Chart
What is Ocular Therapeutix's stock price today?
-
The Ocular Therapeutix share price today is $6.17
The current trend is relatively stagnant and OCUL is experiencing slight buying pressure.
ANAB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.86 | Buy |
| Relative Strength Index (14 RSI): | 55.84 | Buy |
| Chaikin Money Flow: | 41464 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.44 - 25.84) | Buy |
| Bollinger Bands (100): | (21.39 - 25.15) | Buy |
OCUL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.26 | Sell |
| Relative Strength Index (14 RSI): | 49.06 | Sell |
| Chaikin Money Flow: | 169488 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.84 - 6.68) | Buy |
| Bollinger Bands (100): | (4.58 - 8.98) | Sell |
ANAB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.1 | Sell |
| 20-day SMA: | 23.74 | Buy |
| 50-day SMA: | 22.9 | Buy |
| 200-day SMA: | 20.56 | Buy |
| 8-day EMA: | 25.06 | Buy |
| 20-day EMA: | 24.23 | Buy |
| 50-day EMA: | 23.36 | Buy |
| 200-day EMA: | 21.8 | Buy |
OCUL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.96 | Buy |
| 20-day SMA: | 5.48 | Buy |
| 50-day SMA: | 7.4 | Sell |
| 200-day SMA: | 5.01 | Buy |
| 8-day EMA: | 6.01 | Buy |
| 20-day EMA: | 6.05 | Buy |
| 50-day EMA: | 6.62 | Sell |
| 200-day EMA: | 5.79 | Buy |
AnaptysBio Earnings Growth & ANAB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.07 per share, an increase this year of $0.20 per share, and an increase next year of $0.14 per share.
Ocular Therapeutix Earnings Growth & OCUL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.19 per share, and an increase next year of $0.26 per share.
AnaptysBio Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ocular Therapeutix Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||